Medicare Enrolled
Dr. Vahan Kassabian, M.D.
Urology Physician · Roswell, GA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Speaking/Promotional
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Kassabian from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Kassabian?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Kassabian
Dr. Vahan Kassabian is an urology physician in Roswell, GA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Kassabian performed 5,751 Medicare services across 1,531 unique beneficiaries.
Between the years covered by Open Payments, Dr. Kassabian received a total of $1,668,748 from 84 pharmaceutical and/or device companies across 1901 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in urology physician. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Kassabian is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 17% volume in GA
$1,668,748 industry payments
Medicare Practice Summary
Medicare Utilization ↗5,751
Medicare services
Top 17% in GA for urology physician
1,531
Unique beneficiaries
$41
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~303 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Denosumab injection (Prolia/Xgeva) | 2,940 | $18 | $85 |
| Leuprolide injectable, camcevi, 1 mg | 798 | $63 | $345 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
511 | $91 | $465 |
| Bladder ultrasound after voiding An ultrasound scan performed after urination to measure the amount of urine remaining in the bladder. |
275 | $8 | $39 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
260 | $63 | $328 |
| Automated urinalysis An automated laboratory test performed on a urine sample to analyze its chemical and physical properties. The procedure uses machinery to detect various substances and cells within the urine. |
253 | $2 | $8 |
| Complete ultrasound of retroperitoneum An ultrasound examination of the structures located behind the abdominal cavity. |
134 | $79 | $400 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
108 | $114 | $605 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 99 | $134 | $707 |
| Urinalysis for bacteria A urine test to check for the presence of bacteria. This procedure analyzes a urine sample to detect bacterial growth. |
57 | $29 | $111 |
| Subcutaneous or intramuscular chemotherapy injection This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle. |
52 | $27 | $124 |
| Cystourethroscopy A diagnostic exam of the bladder and urethra using an endoscope to visually inspect the urinary tract. |
41 | $173 | $885 |
| Prostate gland biopsy A procedure to remove small samples of tissue from the prostate gland for laboratory examination. |
40 | $92 | $490 |
| Ultrasound guidance for needle placement Use of ultrasound imaging to guide the precise placement of a needle during a medical procedure. |
40 | $23 | $214 |
| Imaging of urinary tract with contrast An imaging test of the urinary tract performed after a contrast agent is injected to enhance visibility of the structures. |
36 | $19 | $283 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
36 | $11 | $52 |
| Ureteral stent insertion via cystoscopy A tube is placed into the ureter using an endoscope inserted through the bladder. |
19 | $93 | $476 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
18 | $74 | $409 |
| Bladder irrigation and/or instillation This procedure involves flushing the bladder with fluid to clear it or introducing medication directly into the bladder. |
12 | $30 | $279 |
| Transurethral prostate removal with electrocautery This procedure involves removing the prostate gland through the urethra using an endoscope and an electrocautery knife to control bleeding. |
11 | $568 | $2,634 |
| Complete ultrasound of abdomen and pelvis blood flow This procedure uses sound waves to create images of blood flow in the arteries and veins of the abdomen and pelvis. It evaluates the rate and direction of blood movement within these vessels. |
11 | $206 | $975 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
0.3% high complexity
62.0% medium
37.7% routine
Industry Payment Transparency
Open Payments through 2024 ↗$1,668,748
Total received (2018-2024)
Avg $238,393/year across 7 years
Top 0% in GA for urology physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
84
Companies
1,901
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$1,554,193 (93.1%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$83,182 (5.0%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$31,373 (1.9%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$244,506
2023
$269,752
2022
$262,310
2021
$163,005
2020
$138,255
2019
$254,428
2018
$336,493
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Merck Sharp & Dohme LLC
$63,151
Sumitomo Pharma America, Inc.
$31,727
UROGEN PHARMA, INC.
$30,802
Astellas Pharma US Inc
$30,045
Janssen Biotech, Inc.
$27,668
Dendreon Pharmaceuticals LLC
$25,048
Bayer Healthcare Pharmaceuticals Inc.
$8,286
PFIZER INC.
$6,621
SN Holdings, LLC
$5,817
PROGENICS PHARMACEUTICALS, INC.
$4,931
AstraZeneca Pharmaceuticals LP
$3,713
Ferring Pharmaceuticals Inc.
$2,312
Telix Pharmaceuticals
$1,863
Medtronic, Inc.
$962
Teleflex LLC
$319
Tempus AI, Inc
$239
Novartis Pharmaceuticals Corporation
$211
Astellas Pharma Inc
$141
Blue Earth Diagnostics Limited
$108
Canon Medical Systems USA, Inc.
$82
SUN PHARMACEUTICAL INDUSTRIES INC.
$65
AngioDynamics, Inc.
$57
Myriad Genetic Laboratories, Inc.
$57
Endo USA, Inc.
$54
Endo Pharmaceuticals Inc.
$49
Laborie Medical Technologies Corp.
$38
Antares Pharma, Inc.
$37
Tolmar, Inc.
$28
Pacira Pharmaceuticals Incorporated
$26
ABC Home Medical Supply, Inc.
$21
ABBVIE INC.
$19
Janssen Scientific Affairs, LLC
$10
Top 3 companies account for 51.4% of 2024 payments
All-time payments by company (2018-2024) ›
Astellas Pharma US Inc
$267,984
Janssen Biotech, Inc.
$252,660
Dendreon Pharmaceuticals LLC
$145,386
Merck Sharp & Dohme LLC
$140,656
Bayer HealthCare Pharmaceuticals Inc.
$120,649
Janssen Scientific Affairs, LLC
$96,391
Merck Sharp & Dohme Corporation
$84,577
AstraZeneca Pharmaceuticals LP
$70,903
Sumitomo Pharma America, Inc.
$70,567
PFIZER INC.
$65,762
UROGEN PHARMA, INC.
$50,669
Bayer Healthcare Pharmaceuticals Inc.
$47,946
SN Holdings, LLC
$42,530
Myovant Sciences Inc.
$38,532
UroGen Pharma, Inc.
$38,312
Progenics Pharmaceuticals, Inc.
$25,938
UroGPO LLC
$24,932
Amgen Inc.
$23,232
TOLMAR Pharmaceuticals, Inc.
$22,385
Janssen Pharmaceuticals, Inc
$7,756
Clovis Oncology, Inc.
$6,113
PROGENICS PHARMACEUTICALS, INC.
$4,931
Astellas Pharma Global Development
$2,935
Ferring Pharmaceuticals Inc.
$2,403
E.R. Squibb & Sons, L.L.C.
$2,359
Telix Pharmaceuticals
$1,880
Medtronic, Inc.
$1,468
EDAP TECHNOMED INC
$946
AngioDynamics, Inc.
$730
Teleflex LLC
$706
Blue Earth Diagnostics Limited
$703
Endo Pharmaceuticals Inc.
$700
Profound Medical Corp.
$584
Novartis Pharmaceuticals Corporation
$439
Lexington Medical, Inc.
$382
Baxter Healthcare
$370
NeoTract Inc.
$369
Boston Scientific Corporation
$334
Tempus AI, Inc
$239
BOSTON SCIENTIFIC CORPORATION
$237
PROCEPT BioRobotics Corporation
$228
Ambu Inc.
$169
Astellas Pharma Inc
$141
ACCORD HEALTHCARE, INC.
$137
Metuchen Pharmaceuticals
$121
Myriad Genetic Laboratories, Inc.
$112
Antares Pharma, Inc.
$88
Ethicon US, LLC
$87
Canon Medical Systems USA, Inc.
$82
SUN PHARMACEUTICAL INDUSTRIES INC.
$65
Medtronic USA, Inc.
$65
C. R. BARD, INC. & SUBSIDIARIES
$62
Tolmar, Inc.
$58
Endo USA, Inc.
$54
Coloplast Corp
$51
Laborie Medical Technologies Corp.
$51
Roche Diagnostics Corporation
$46
UROVANT SCIENCES INC
$40
Sun Pharmaceutical Industries Inc.
$33
Accord Healthcare, Inc.
$30
Allergan Inc.
$30
180 Medical, Inc.
$27
Pacira Pharmaceuticals Incorporated
$26
Rochester Medical Corporation
$24
Palette Life Sciences, Inc.
$23
Allergan, Inc.
$21
ABC Home Medical Supply, Inc.
$21
AbbVie, Inc.
$20
Philips Electronics North America Corporation
$20
ABBVIE INC.
$19
Eli Lilly and Company
$18
Gilead Sciences, Inc.
$18
Supernus Pharmaceuticals, Inc.
$18
Clarus Therapeutics Inc.
$17
Retrophin, Inc.
$16
Egalet US Inc
$15
COLOPLAST CORP
$15
Photocure Inc
$14
MEDIVATION FIELD SOLUTIONS LLC
$14
Kowa Pharmaceuticals America, Inc.
$14
AMAG Pharmaceuticals, Inc.
$12
Olympus America Inc.
$12
Avadel Specialty Pharmaceuticals, LLC
$12
Travere Therapeutics, Inc.
$9
Top 3 companies account for 39.9% of all-time payments
Associated products mentioned in payments ›
(815) Thiola · (8874) inCourage · ADSTILADRIN · AMS · AQUABEAM ROBOTIC SYSTEM · AVEED · AVYCAZ · Advantage System · Aeon Endostapler · Axumin · BOTOX · CAMCEVI · CERTUS 140 MICROWAVE ABLATION SYSTEM · CLENPIQ · Cysview · EDEX · ELIGARD · ERLEADA · EndoSheath Technology · Erleada · Exparel · FIRMAGON · FLEXIVA · FLOSEAL · GEMTESA · GENERAL - FEMALE SUI · GENERAL DEVICE(S) · ILLUCCIX · IMFINZI · INLYTA · INTERSTIM · JATENZO · JELMYTO · KEYTRUDA · LITHOVUE · LUPRON DEPOT · LYNPARZA · Livalo · Lupron · MYRBETRIQ · Myrbetriq · NANOKNIFE · NOCDURNA · Noctiva · Non-Covered · Nubeqa · OPDIVO · ORGOVYX · PLUVICTO · POSLUMA · PROLARIS · PROVENGE · PYLARIFY · Prolaris · Prolia · RUBRACA · Rubraca · SOLESTA · SPACEOAR VUE · SPRIX · SUTENT · SpaceOAR VUE System - 10mL · SpeediCath · Stendra · TALZENNA · TISSEEL · TOVIAZ · Thiola · Titan · Trodelvy · Tulsa-Pro · UROLIFT · UroLift · UroLift System · VERZENIO · VYLEESI · XGEVA · XIAFLEX · XT CDX · XTANDI · XYOSTED · Xofigo · Xtandi · YONSA · ZYTIGA · iTIND System · rezum Generator
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (93%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in urology physician and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 0% for urology physician in GA.
Geographic Context
Urology physicians within 10 mi
160
Per 100K population
15.0
County median income
$91,490
Nearest hospital
WELLSTAR NORTH FULTON MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Kassabian is a clinical cardiology specialist, with above-average Medicare volume (top 17% in GA), with speaking/promotional industry engagement in the top 0% of GA peers, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Kassabian experienced with denosumab injection (prolia/xgeva)?
Based on Medicare claims data, Dr. Kassabian performed 2,940 denosumab injection (prolia/xgeva) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Kassabian receive payments from pharmaceutical companies?
Yes. Dr. Kassabian received a total of $1,668,748 from 84 companies across 1,901 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Kassabian's costs compare to other urology physicians in Roswell?
Dr. Kassabian's average Medicare payment per service is $41. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Kassabian) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Urology Physicians in Roswell
Browse urology physicians in Roswell ranked by procedure volume and transparency data.
Highest volume
Top Urology Physicians in GA
Urology physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Urology Physicians in GA
Which GA urology physicians receive the most from drug and device companies.
By company
Astellas Pharma US Inc Payments to Doctors
See all physicians who received payments from Astellas Pharma US Inc.
By company
Janssen Biotech, Inc. Payments to Doctors
See all physicians who received payments from Janssen Biotech, Inc.
By company
Dendreon Pharmaceuticals LLC Payments to Doctors
See all physicians who received payments from Dendreon Pharmaceuticals LLC.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology